Cyclin-dependent kinase inhibitor p21, via its C-terminal domain, is essential for resolution of murine inflammatory arthritis

Genetic Analysis of the Role of the PI3K-Akt Pathway in Lipopolysaccharide-Induced Cytokine and Tissue Factor Gene Expression in Monocytes/Macrophages

(2014) J. P. Luyendyk et al.   JOURNAL OF IMMUNOLOGY

Bim-Bcl-2 homology 3 mimetic therapy is effective at suppressing inflammatory arthritis through the activation of myeloid cell apoptosis

(2010) John C. Scatizzi et al.   ARTHRITIS AND RHEUMATISM

The CDK domain of p21 is a suppressor of IL-1β-mediated inflammation in activated macrophages

(2009) John C. Scatizzi et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Regulation of macrophage activation and septic shock susceptibilityviap21(WAF1/CIP1)

(2009) Marianna Trakala et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

A regulatory SNP at position −899 in CDKN1A is associated with systemic lupus erythematosus and lupus nephritis

(2009) K Kim et al.   GENES AND IMMUNITY

Synovial Tissue Sublining CD68 Expression Is a Biomarker of Therapeutic Response in Rheumatoid Arthritis Clinical Trials: Consistency Across Centers

(2009) B. BRESNIHAN et al.   JOURNAL OF RHEUMATOLOGY

BH3-only proteins in rheumatoid arthritis: potential targets for therapeutic intervention

(2009) J Hutcheson et al.   ONCOGENE

Intracellular signal pathways: Potential for therapies

(2009) Melissa Mavers et al.   Current Rheumatology Reports

Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints

(2008) K Polzer et al.   ANNALS OF THE RHEUMATIC DISEASES

Genetic Background and the Dilemma of Translating Mouse Studies to Humans

(2008) Juan Rivera et al.   IMMUNITY

PI3K/Akt: getting it right matters

(2008) T F Franke   ONCOGENE